000153 豐原藥業
按盤價 
5.560 0.000 (0.000%)
5.560 0.000 (0.000%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.455 | 8.805 | 8.900 | 7.795 | 7.580 |
| 總資產報酬率 ROA (%) | 1.034 | 3.595 | 3.622 | 3.196 | 2.883 |
| 投入資產回報率 ROIC (%) | 1.523 | 5.265 | 5.242 | 4.651 | 4.207 | 邊際利潤分析 |
| 銷售毛利率 (%) | 25.702 | 25.708 | 28.228 | 29.748 | 34.663 |
| 營業利潤率 (%) | 5.941 | 4.988 | 5.047 | 4.290 | 3.931 |
| 息稅前利潤/營業總收入 (%) | 6.546 | 5.629 | 5.799 | 5.428 | 5.383 |
| 淨利潤/營業總收入 (%) | 4.137 | 3.679 | 3.770 | 3.227 | 3.074 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.747 | 82.302 | 76.544 | 78.096 | 62.449 |
| 價值變動淨收益/利潤總額(%) | -15.639 | -0.735 | 7.327 | 6.087 | 12.693 |
| 營業外收支淨額/利潤總額(%) | 0.305 | 0.763 | 0.096 | 1.975 | 5.472 | 償債能力分析 |
| 流動比率 (X) | 0.943 | 0.945 | 0.886 | 0.964 | 0.842 |
| 速動比率 (X) | 0.690 | 0.660 | 0.588 | 0.627 | 0.586 |
| 資產負債率 (%) | 58.097 | 56.304 | 60.737 | 56.361 | 60.179 |
| 帶息債務/全部投入資本 (%) | 30.125 | 27.448 | 36.839 | 29.401 | -- |
| 股東權益/帶息債務 (%) | 202.672 | 229.778 | 153.594 | 208.781 | 150.114 |
| 股東權益/負債合計 (%) | 70.998 | 76.417 | 63.677 | 76.136 | 64.595 |
| 利息保障倍數 (X) | 11.154 | 9.334 | 7.765 | 5.163 | 4.395 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 72.970 | 62.472 | 60.872 | 66.034 | 0.000 |
| 存貨周轉天數 (天) | 61.760 | 72.125 | 84.810 | 82.925 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/06/2024 11:01 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
